Institutional Ownership Nurix Therapeutics, Inc. (NRIX)
This table provides information about the institutional ownership of Nurix Therapeutics, Inc. (NRIX). We have compiled data on the 184 institutions that hold shares in the stock, with a total of 77.6 Million shares, which have been reported (via 13F filing form) to have a value of $993 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Qube Research & Technologies LTD
London, X0 |
Nov 14, 2025 Q3 2025 |
716,535
shares
|
$9.17 Million
0.01% of portfolio
|
Q3 2025
Added 100.86%
|
|
|
Northern Trust Corp
Chicago, IL |
Nov 14, 2025 Q3 2025 |
680,009
shares
|
$8.7 Million
0.0% of portfolio
|
Q3 2025
Added 4.05%
|
|
|
Goldman Sachs Group Inc
New York, NY |
Nov 14, 2025 Q3 2025 |
622,299
shares
|
$7.97 Million
0.0% of portfolio
|
Q3 2025
Added 6.46%
|
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Nov 14, 2025 Q3 2025 |
565,305
shares
|
$7.24 Million
0.0% of portfolio
|
Q3 2025
Reduced 64.42%
|
|
|
Algert Global LLC
San Francisco, CA |
Nov 14, 2025 Q3 2025 |
563,837
shares
|
$7.22 Million
0.09% of portfolio
|
Q3 2025
Added 392.44%
|
|
|
Handelsbanken Fonder Ab
|
Nov 12, 2025 Q3 2025 |
520,000
shares
|
$6.66 Million
0.02% of portfolio
|
Q3 2025
New holding
|
|
|
Bank Of America Corp
Charlotte, NC |
Nov 14, 2025 Q3 2025 |
481,054
shares
|
$6.16 Million
0.0% of portfolio
|
Q3 2025
Added 47.02%
|
|
|
Patient Square Capital LP
Menlo Park, CA |
Nov 10, 2025 Q3 2025 |
437,237
shares
|
$5.6 Million
1.08% of portfolio
|
Q3 2025
Added 6.05%
|
|
|
Dimensional Fund Advisors LP
Austin, TX |
Nov 12, 2025 Q3 2025 |
430,962
shares
|
$5.52 Million
0.0% of portfolio
|
Q3 2025
Added 0.91%
|
|
|
Nuveen Asset Management, LLC
Chicago, IL |
Feb 14, 2025 Q4 2024 |
409,637
shares
|
$5.24 Million
0.0% of portfolio
|
Q4 2024
Reduced 39.18%
|
|
|
Ubs Group Ag
|
Nov 13, 2025 Q3 2025 |
362,546
shares
|
$4.64 Million
0.0% of portfolio
|
Q3 2025
Reduced 77.18%
|
|
|
Integral Health Asset Management, LLC
|
Nov 14, 2025 Q3 2025 |
350,000
shares
|
$4.48 Million
0.25% of portfolio
|
Q3 2025
Added 12.9%
|
|
|
Rhenman & Partners Asset Management Ab
Stockholm, V7 |
Nov 13, 2025 Q3 2025 |
347,500
shares
|
$4.45 Million
0.38% of portfolio
|
Q3 2025
Added 87.84%
|
|
|
Cubist Systematic Strategies, LLC
Stamford, CT |
Nov 14, 2025 Q3 2025 |
327,952
shares
|
$4.2 Million
0.02% of portfolio
|
Q3 2025
New holding
|
|
|
Ponoi Management, LLC
San Francisco, CA |
Nov 14, 2022 Q3 2022 |
327,123
shares
|
$4.19 Million
5.82% of portfolio
|
Q2 2022
Added 0.0%
|
|
|
Ponoi Ii Management, LLC
San Francisco, CA |
Nov 14, 2022 Q3 2022 |
327,123
shares
|
$4.19 Million
11.14% of portfolio
|
Q4 2021
Reduced 41.75%
|
|
|
Arrow Mark Colorado Holdings LLC
Denver, CO |
Nov 14, 2025 Q3 2025 |
314,762
shares
|
$4.03 Million
0.06% of portfolio
|
Q4 2023
New holding
|
|
|
Wasatch Advisors Inc
Salt Lake City, UT |
Nov 14, 2025 Q3 2025 |
313,889
shares
|
$4.02 Million
0.02% of portfolio
|
Q3 2025
Reduced 35.54%
|
|
|
Bessemer Group Inc
Woodbridge, NJ |
Nov 05, 2025 Q3 2025 |
306,003
shares
|
$3.92 Million
0.0% of portfolio
|
Q4 2024
Reduced 0.02%
|
|
|
Candriam S.C.A.
|
Nov 05, 2025 Q3 2025 |
262,384
shares
|
$3.36 Million
0.01% of portfolio
|
Q2 2025
Reduced 55.45%
|
|
|
Jane Street Group, LLC
New York, NY |
Nov 13, 2025 Q3 2025 |
258,651
shares
|
$3.31 Million
0.0% of portfolio
|
Q3 2025
New holding
|
|
|
Wellington Management Group LLP
Boston, MA |
Nov 14, 2025 Q3 2025 |
255,790
shares
|
$3.27 Million
0.0% of portfolio
|
Q3 2025
Reduced 82.54%
|
|
|
Marshall Wace, LLP
London, X0 |
Nov 13, 2025 Q3 2025 |
246,788
shares
|
$3.16 Million
0.0% of portfolio
|
Q3 2025
New holding
|
|
|
Kennedy Capital Management, Inc.
St Louis, MO |
Nov 13, 2025 Q3 2025 |
246,743
shares
|
$3.16 Million
0.05% of portfolio
|
Q3 2025
Reduced 4.29%
|
|
|
Barclays PLC
London, X0 |
Nov 12, 2025 Q3 2025 |
245,095
shares
|
$3.14 Million
0.0% of portfolio
|
Q3 2025
Reduced 3.84%
|
|